No headlines found.
Globe Newswire (Mon, 23-Mar 8:30 AM ET)
NovaBay Pharmaceuticals Inc is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The company's initial digital asset focus is the Sky protocol ecosystem, with SKY as its core holding. Through staking and other on-chain activities, it seeks to generate protocol-level economic returns while maintaining rigorous governance and risk management oversight.
Novabay Pharmaceuticals trades on the AMEX stock market under the symbol NBY.
As of April 10, 2026, NBY stock price was flat at $1.95 with million shares trading.
NBY has a beta of 2.96, meaning it tends to be more sensitive to market movements. NBY has a correlation of 0.02 to the broad based SPY ETF.
NBY has a market cap of $51.92 million. This is considered a Micro Cap stock.
In the last 3 years, NBY traded as high as $99.75 and as low as $.33.
The top ETF exchange traded funds that NBY belongs to (by Net Assets): VXF.
NBY has outperformed the market in the last year with a price return of +306.1% while the SPY ETF gained +30.9%. However, in the short term, NBY had mixed performance relative to the market. It has underperformed in the last 3 months, returning -98.0% vs -1.8% return in SPY. But in the last 2 weeks, NBY shares have fared better than the market returning +30.0% compared to SPY +7.2%.
NBY support price is $1.75 and resistance is $2.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NBY shares will trade within this expected range on the day.
